SCHEMBL21786869

SCHEMBL21786869

CC[C@H]1O[C@@H](n2ccc(N)nc2=O)C[C@H]1OCSSC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
LMNA P02545 3/20 0.41
PDE3A Q14432 3/20 0.41
CACNA1F O60840 2/20 0.41
ALB P02768 2/20 0.41
MAPT P10636 2/20 0.41
CACNA1D Q01668 2/20 0.41
CACNA1S Q13698 2/20 0.41
CACNA1C Q13936 2/20 0.41
THRB P10828 1/20 0.38
MTOR P42345 1/20 0.38
MDM2 Q00987 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
POLG P54098 2/20 0.37
P2RY2 P41231 3/20 0.36
P2RY4 P51582 3/20 0.36
P2RY6 Q15077 2/20 0.36
PDE4D Q08499 1/20 0.36
SLC29A1 Q99808 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21787138 1.00 POLB (0.43) POLBLMNAPDE3ACACNA1FALB
SCHEMBL21786915 0.92 POLB (0.42) POLBLMNAPDE3ACACNA1FALB
SCHEMBL24913387 0.92 POLB (0.43) POLBLMNAPDE3ACACNA1FALB
SCHEMBL21786857 0.83 POLB (0.42) POLBLMNAPDE3ACACNA1FALB
SCHEMBL23734249 0.83 POLG (0.57) POLBPOLGP2RY2P2RY4P2RY6
SCHEMBL23734381 0.83 POLB (0.40) POLBLMNAPDE3ACACNA1FALB
SCHEMBL23734154 0.83 POLG (0.57) POLBPOLGP2RY2P2RY4P2RY6
SCHEMBL21786933 0.83 POLG (0.57) POLBPOLGP2RY2P2RY4P2RY6
SCHEMBL14512782 0.82 POLB (0.49) POLBLMNAPDE3ACACNA1FALB
SCHEMBL12015129 0.82 POLB (0.49) POLBLMNAPDE3ACACNA1FALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200069717-A1 NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200069717-A1 NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF POLRMT, NSUN2, RNGTT POLB 12/4885LMNA 370/4885PDE3A 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.